All Stories

  1. Reversal of an unfavorable effect of hydrochlorothiazide compared to angiotensin converting enzyme inhibitor on serum uric acid and oxypurine levels by estrogen–progestin therapy in hypertensive postmenopausal women

    Article • Current Medical Research and Opinion, June 2019, Taylor & Francis

    Dr Katarzyna Malaczynska-Rajpold

  2. An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil

    Article • BMC Pulmonary Medicine, December 2017, Springer Science + Business Media

    Dr Katarzyna Malaczynska-Rajpold

  3. Balloon atrial septostomy in pulmonary arterial hypertension: A beneficial effect on the control of rhythm abnormalities

    Article • Cardiology Journal, October 2016, VM Media SP. zo.o VM Group SK

    Dr Katarzyna Malaczynska-Rajpold

  4. The “bouncing” catheter

    Article • Cardiology Journal, October 2016, VM Media SP. zo.o VM Group SK

    Dr Katarzyna Malaczynska-Rajpold

  5. The Management of Supraventricular Tachyarrhythmias in Patients with Pulmonary Arterial Hypertension

    Article • Heart Lung and Circulation, May 2016, Elsevier

    Dr Katarzyna Malaczynska-Rajpold

  6. Znaczna poprawa kliniczna pacjenta leczonego sildenafilem z powodu nadciśnienia płucnego związanego z nadciśnieniem wrotnym

    Article • Folia Cardiologica, October 2015, VM Media SP. zo.o VM Group SK

    Dr Katarzyna Malaczynska-Rajpold

  7. Unresectable cardiac pseudoneoplasms causing ventricular tachycardia

    Article • Cardiovascular Pathology, November 2014, Elsevier

    Dr Katarzyna Malaczynska-Rajpold

  8. Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic

    Article • Clinical Research in Cardiology, September 2014, Springer Science + Business Media

    Dr Katarzyna Malaczynska-Rajpold

  9. THE EVALUATION OF CARDIOPULMONARY EXERCISE TEST IN PATIENTS WITH CHRONIC HEART FAILURE IN RELATION TO GENERATED BLOOD PRESSURE

    Article • Journal of Hypertension, June 2011, Wolters Kluwer Health

    Dr Katarzyna Malaczynska-Rajpold

  10. MODIFIABLE CARDIOVASCULAR RISK FACTORS- ARE THEY STILL PROBLEM FOR HYPERTENSIVE PARIENTS?: PP.28.130

    Article • Journal of Hypertension, June 2010, Wolters Kluwer Health

    Dr Katarzyna Malaczynska-Rajpold

  11. KIDNEY FUNCTION EVALUATION IN THE INTERPRETATION OF CARDIOVASCULAR RISK IN THE GROUP OF HYPERTENSIVE PATIENTS: PP.30.208

    Article • Journal of Hypertension, June 2010, Wolters Kluwer Health

    Dr Katarzyna Malaczynska-Rajpold

  12. ASSESSMENT OF METABOLIC PARAMETERS AND RENAL FUNCTION AS PROGNOSTIC FACTORS IN CARDIOVASCULAR DISORDERS IN HYPERTENSIVE PATIENTS: PP.35.474

    Article • Journal of Hypertension, June 2010, Wolters Kluwer Health

    Dr Katarzyna Malaczynska-Rajpold

  13. WAIST CIRCUMFERENCE AS A CARDIOVASCULAR RISK FACTOR IN A POPULATION EXAMINED IN A PROPHYLACTIC CAMPAIGN LADIES IN RED: PP.34.381

    Article • Journal of Hypertension, June 2010, Wolters Kluwer Health

    Dr Katarzyna Malaczynska-Rajpold